JP2018529345A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529345A5 JP2018529345A5 JP2018515528A JP2018515528A JP2018529345A5 JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5 JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- seq
- sample
- mammal
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 17
- 210000003719 b-lymphocyte Anatomy 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 7
- 230000011987 methylation Effects 0.000 claims 7
- 238000007069 methylation reaction Methods 0.000 claims 7
- 239000000523 sample Substances 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 108091093088 Amplicon Proteins 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 4
- 238000004458 analytical method Methods 0.000 claims 4
- 238000012544 monitoring process Methods 0.000 claims 4
- 102000001770 Low Density Lipoprotein Receptor-Related Protein-5 Human genes 0.000 claims 3
- 108010015167 Low Density Lipoprotein Receptor-Related Protein-5 Proteins 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 108091029523 CpG island Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 claims 1
- 108700009124 Transcription Initiation Site Proteins 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 239000012620 biological material Substances 0.000 claims 1
- 238000001369 bisulfite sequencing Methods 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 230000017858 demethylation Effects 0.000 claims 1
- 238000010520 demethylation reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 230000003325 follicular Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 210000000822 natural killer cell Anatomy 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1516972.5A GB201516972D0 (en) | 2015-09-25 | 2015-09-25 | LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells |
| GB1516972.5 | 2015-09-25 | ||
| PCT/EP2016/072579 WO2017050916A1 (en) | 2015-09-25 | 2016-09-22 | Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018529345A JP2018529345A (ja) | 2018-10-11 |
| JP2018529345A5 true JP2018529345A5 (https=) | 2019-10-31 |
Family
ID=54544102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515528A Pending JP2018529345A (ja) | 2015-09-25 | 2016-09-22 | 免疫細胞、特にｂ細胞の同定のためのエピジェネティックマーカーとしてのｌｒｐ５ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11643687B2 (https=) |
| EP (1) | EP3353318B1 (https=) |
| JP (1) | JP2018529345A (https=) |
| CN (1) | CN108026578A (https=) |
| GB (1) | GB201516972D0 (https=) |
| HK (1) | HK1257122A1 (https=) |
| WO (1) | WO2017050916A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3652344A1 (en) * | 2017-07-13 | 2020-05-20 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Dna targets as tissue-specific methylation markers |
| US12005080B2 (en) | 2018-03-26 | 2024-06-11 | Oricell Therapeutics Co., Ltd. | Method for promoting proliferation of immune cells |
| DE102018112644B4 (de) | 2018-05-25 | 2020-06-10 | Epiontis Gmbh | CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen |
| DE102018116353B4 (de) * | 2018-07-05 | 2020-06-10 | Epiontis Gmbh | Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening |
| DE102020108560B4 (de) | 2020-03-27 | 2022-03-03 | Precision For Medicine Gmbh | CBX6 als epigenetischer Marker für die Identifizierung von Immunzellen, insbesondere Gedächtnis-B-Zellen |
| CN119372296B (zh) * | 2024-12-24 | 2025-06-13 | 北京致谱医学检验实验室有限公司 | 基于基因甲基化检测实现人b淋巴细胞计数的试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2410253C (en) * | 2000-05-26 | 2010-06-15 | Genome Therapeutics Corporation | Regulating lipid levels via the zmax1 or hbm gene |
| ES2367012T3 (es) * | 2006-02-28 | 2011-10-27 | Charite-Universitätsmedizin Berlin | Detección y control de calidad de linfocitos t reguladores a través del análisis de metilación del adn del gen foxp3. |
| CN101909630A (zh) * | 2007-11-02 | 2010-12-08 | 新加坡科技研究局 | 预防和治疗肿瘤的方法和化合物 |
| US20110104695A1 (en) * | 2009-11-05 | 2011-05-05 | Epigenomics Ag | Methods of predicting therapeutic efficacy of cancer therapy |
| WO2012045888A1 (en) * | 2010-10-08 | 2012-04-12 | Epiontis Gmbh | Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes |
| WO2013033627A2 (en) | 2011-09-01 | 2013-03-07 | The Regents Of The University Of California | Diagnosis and treatment of arthritis using epigenetics |
| JP6590790B2 (ja) * | 2013-04-19 | 2019-10-16 | エピオンティス ゲーエムベーハー | 生体サンプルにおける定量的細胞組成を特定する方法 |
| EP3149206B1 (en) * | 2014-05-30 | 2020-09-02 | Robert Philibert | Dna methylation status as a biomarker of alcohol use and abstinence |
-
2015
- 2015-09-25 GB GBGB1516972.5A patent/GB201516972D0/en not_active Ceased
-
2016
- 2016-09-22 HK HK18116376.0A patent/HK1257122A1/zh unknown
- 2016-09-22 US US15/752,072 patent/US11643687B2/en active Active
- 2016-09-22 CN CN201680052685.1A patent/CN108026578A/zh active Pending
- 2016-09-22 JP JP2018515528A patent/JP2018529345A/ja active Pending
- 2016-09-22 EP EP16770025.1A patent/EP3353318B1/en active Active
- 2016-09-22 WO PCT/EP2016/072579 patent/WO2017050916A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018529345A5 (https=) | ||
| Jara-Acevedo et al. | Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications | |
| Houseman et al. | DNA methylation in whole blood: uses and challenges | |
| Agnelli et al. | Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma | |
| JP2012511917A5 (https=) | ||
| EP3327141B1 (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| JP2018529346A5 (https=) | ||
| WO2007121276A3 (en) | Enrichment of circulating fetal dna | |
| JP2018534910A5 (https=) | ||
| CN104818316B (zh) | 用于筛查柳氮磺胺吡啶所致皮肤药物不良反应的人类白细胞抗原基因检测试剂盒 | |
| JP2022141905A (ja) | 移植拒絶リスクを予測する新規の方法 | |
| HK1257122A1 (zh) | Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物 | |
| Tomusiak et al. | Development of a novel epigenetic clock resistant to changes in immune cell composition | |
| Ivison et al. | Natural killer cell receptors and ligands are associated with markers of HIV-1 persistence in chronically infected ART suppressed patients | |
| Orsenigo et al. | Unifying considerations and evidence of macrophage activation mosaicism through human CSF1R and M1/M2 genes | |
| Genshaft et al. | Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity | |
| Brownlie et al. | Distinct lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza | |
| JP2021502806A5 (https=) | ||
| CN105349641A (zh) | 急性心肌梗死相关基因serpinb13及其应用 | |
| CA2842266A1 (en) | Epigenetic marker for the identification of natural killer cells | |
| JP2021502809A5 (https=) | ||
| Amato et al. | Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal | |
| Blanc et al. | Impact of a CD4 gene haplotype on the immune response in minipigs | |
| Nguyen et al. | A Composite Epigenetic Biomarker of FOXP3/TIGIT Correlates With Regulatory T Cell Numbers in Cord Blood and Is Associated With Subsequent Food Allergy | |
| WO2015052190A1 (en) | Predicting increased risk for cancer |